Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory diseases
Manufacturing
Savara's lung disease asset hit with FDA refuse-to-file letter
Despite hiring a CCO and sponsoring disease awareness efforts last year, Savara will have to wait a while longer for a potential approval.
Fraiser Kansteiner
May 27, 2025 10:35am
Chiesi unveils €430M investment in new Italian inhaler facility
Mar 27, 2025 10:47am
GSK posts COPD win for Nucala as rival nears possible approval
Sep 6, 2024 9:40am
Jane Seymour backs Insmed's push to tackle gender and age biases
Mar 5, 2024 6:41am
CDC ad campaign seeks to stir emotions to drive vaccine uptake
Dec 13, 2023 8:03am
Respiratory patient groups decry pricing, access to lung meds
Jul 24, 2023 7:34am